These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31196492)

  • 1. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis.
    He J; Yang Z; Wu Z; Wang L; Xu S; Zou Q; Yuan Y; Li D
    Onco Targets Ther; 2019; 12():2955-2965. PubMed ID: 31114239
    [No Abstract]   [Full Text] [Related]  

  • 3. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.
    Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X
    World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent.
    Takahashi T; Kawaji H; Murakawa Y; Hayashizaki Y; Murakami T; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Eur J Surg Oncol; 2021 Feb; 47(2):394-400. PubMed ID: 32878723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
    Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
    Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
    Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S
    J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
    Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
    Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
    Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
    J Surg Oncol; 2020 Nov; 122(6):1094-1105. PubMed ID: 32634266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of Hapto and Gremlin1 expression in extrahepatic cholangiocarcinoma.
    Wu Z; Liu R; Miao X; Li D; Zou Q; Yuan Y; Yang Z
    J Cancer; 2020; 11(1):199-207. PubMed ID: 31892986
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
    Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.